Dr. Martens plc (LON:DOCS – Get Free Report) insider Giles Wilson acquired 32,640 shares of the firm’s stock in a transaction dated Tuesday, March 25th. The stock was bought at an average price of GBX 54 ($0.70) per share, for a total transaction of £17,625.60 ($22,819.26).
Giles Wilson also recently made the following trade(s):
- On Tuesday, March 11th, Giles Wilson purchased 269 shares of Dr. Martens stock. The shares were bought at an average price of GBX 56 ($0.73) per share, for a total transaction of £150.64 ($195.03).
- On Tuesday, February 11th, Giles Wilson acquired 207 shares of Dr. Martens stock. The stock was bought at an average price of GBX 73 ($0.95) per share, with a total value of £151.11 ($195.64).
- On Monday, January 13th, Giles Wilson bought 222 shares of Dr. Martens stock. The stock was purchased at an average price of GBX 68 ($0.88) per share, for a total transaction of £150.96 ($195.44).
Dr. Martens Trading Down 2.3 %
LON:DOCS opened at GBX 52.90 ($0.68) on Friday. The firm has a market capitalization of £513.53 million, a P/E ratio of 7.50, a P/E/G ratio of 6.40 and a beta of 0.11. The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 127.27. The company has a fifty day moving average of GBX 64.97 and a 200 day moving average of GBX 63.56. Dr. Martens plc has a 52 week low of GBX 49.32 ($0.64) and a 52 week high of GBX 99.40 ($1.29).
Dr. Martens Cuts Dividend
Dr. Martens Company Profile
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
See Also
- Five stocks we like better than Dr. Martens
- 3 Best Fintech Stocks for a Portfolio Boost
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Top 3 Beverage Stocks Pouring Out Profits
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.